Edward W. Withrow III - 14 Jan 2022 Form 4 Insider Report for PARALLAX HEALTH SCIENCES, INC.

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 14 Jan 2022
Net transaction value: +$1,238,614
SEC form: 4
Accepted by SEC: 17 Mar 2022, 17:27:56 UTC
Prior SEC filing: 17 Mar 2022
Source filing: View source filing
Reporting owner signature: EDWARD W. WITHROW III

Key filing fact

Edward W. Withrow III filed Form 4 for PARALLAX HEALTH SCIENCES, INC. on 17 Mar 2022.

Key facts

This page summarizes Edward W. Withrow III's Form 4 filing for PARALLAX HEALTH SCIENCES, INC..
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Mar 2022, 17:27.

Change

Previous filing in this sequence was filed on 17 Mar 2022.
Current net transaction value: +$1,238,614.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRLX transaction

COMMON STOCK

Other

Transaction value: $564,062
Shares: +7,050,773
Change %: +9.7%
Price: $0.0800
Shares after: 79,481,565
Date: 14 Jan 2022
Ownership: By Huntington Chase LLC
Footnotes: F1

PRLX transaction

COMMON STOCK

Other

Transaction value: $674,553
Shares: +13,491,053
Change %: +17%
Price: $0.0500
Shares after: 92,972,618
Date: 14 Jan 2022
Ownership: By Huntington Chase LLC
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares issued in connection with conversion of convertible promissory notes and accrued interest.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .